These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes. Mishra S; Gray CB; Miyamoto S; Bers DM; Brown JH Circ Res; 2011 Dec; 109(12):1354-62. PubMed ID: 21998325 [TBL] [Abstract][Full Text] [Related]
6. MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells. Ginnan R; Sun LY; Schwarz JJ; Singer HA Biochem J; 2012 May; 444(1):105-14. PubMed ID: 22360269 [TBL] [Abstract][Full Text] [Related]
7. Cardiomyocyte calcium and calcium/calmodulin-dependent protein kinase II: friends or foes? Zhang T; Miyamoto S; Brown JH Recent Prog Horm Res; 2004; 59():141-68. PubMed ID: 14749501 [TBL] [Abstract][Full Text] [Related]
8. Effects on recovery during acidosis in cardiac myocytes overexpressing CaMKII. Sag CM; Dybkova N; Neef S; Maier LS J Mol Cell Cardiol; 2007 Dec; 43(6):696-709. PubMed ID: 17950750 [TBL] [Abstract][Full Text] [Related]
9. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018 [TBL] [Abstract][Full Text] [Related]
10. The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Backs J; Backs T; Neef S; Kreusser MM; Lehmann LH; Patrick DM; Grueter CE; Qi X; Richardson JA; Hill JA; Katus HA; Bassel-Duby R; Maier LS; Olson EN Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2342-7. PubMed ID: 19179290 [TBL] [Abstract][Full Text] [Related]
11. CaMKIIδ mediates β-adrenergic effects on RyR2 phosphorylation and SR Ca(2+) leak and the pathophysiological response to chronic β-adrenergic stimulation. Grimm M; Ling H; Willeford A; Pereira L; Gray CB; Erickson JR; Sarma S; Respress JL; Wehrens XH; Bers DM; Brown JH J Mol Cell Cardiol; 2015 Aug; 85():282-91. PubMed ID: 26080362 [TBL] [Abstract][Full Text] [Related]
12. Ca2+/calmodulin kinase II-dependent phosphorylation of ryanodine receptors suppresses Ca2+ sparks and Ca2+ waves in cardiac myocytes. Yang D; Zhu WZ; Xiao B; Brochet DX; Chen SR; Lakatta EG; Xiao RP; Cheng H Circ Res; 2007 Feb; 100(3):399-407. PubMed ID: 17234969 [TBL] [Abstract][Full Text] [Related]
15. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Zhang T; Maier LS; Dalton ND; Miyamoto S; Ross J; Bers DM; Brown JH Circ Res; 2003 May; 92(8):912-9. PubMed ID: 12676814 [TBL] [Abstract][Full Text] [Related]
16. Interaction of calcium/calmodulin-dependent protein kinase IIdeltaC with sorcin indirectly modulates ryanodine receptor function in cardiac myocytes. Anthony DF; Beattie J; Paul A; Currie S J Mol Cell Cardiol; 2007 Oct; 43(4):492-503. PubMed ID: 17707398 [TBL] [Abstract][Full Text] [Related]
17. Targeted inhibition of sarcoplasmic reticulum CaMKII activity results in alterations of Ca2+ homeostasis and cardiac contractility. Ji Y; Zhao W; Li B; Desantiago J; Picht E; Kaetzel MA; Schultz Jel J; Kranias EG; Bers DM; Dedman JR Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H599-606. PubMed ID: 16143658 [TBL] [Abstract][Full Text] [Related]
18. Nuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells. Little GH; Bai Y; Williams T; Poizat C J Biol Chem; 2007 Mar; 282(10):7219-31. PubMed ID: 17179159 [TBL] [Abstract][Full Text] [Related]
19. CaMKIIdelta overexpression in hypertrophy and heart failure: cellular consequences for excitation-contraction coupling. Maier LS Braz J Med Biol Res; 2005 Sep; 38(9):1293-302. PubMed ID: 16138211 [TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5. He T; Huang J; Chen L; Han G; Stanmore D; Krebs-Haupenthal J; Avkiran M; Hagenmüller M; Backs J J Mol Cell Cardiol; 2020 Aug; 145():88-98. PubMed ID: 32485181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]